Creation Of Linkage Map Falters, Posing Delay For Genome Project

Researchers, discouraged by mapping's drudgery, doubt that a 5-year plan to finish high-resolution image is now feasible. WASHINGTON--After three years of escalating expectations, rising financial support, and congressional accolades, the Human Genome Initiative has encountered its first major hurdle. A key element of the project has fallen several years behind schedule, in part because peer review panels at the National Institutes of Health decided that some incoming grant proposals on the to

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share


Researchers, discouraged by mapping's drudgery, doubt that a 5-year plan to finish high-resolution image is now feasible.
WASHINGTON--After three years of escalating expectations, rising financial support, and congressional accolades, the Human Genome Initiative has encountered its first major hurdle. A key element of the project has fallen several years behind schedule, in part because peer review panels at the National Institutes of Health decided that some incoming grant proposals on the topic were "boring." Of those scientists who were funded, many have diverted part of their research toward more tantalizing pursuits. The process of catching up may require a dramatic rethinking of many of the strategies of the 15-year, $3 billion project.

The immediate obstacle stems from a lack of progress on the so-called linkage map of the genome. The term refers to a list that links human traits and their associated genes to locations on the human DNA molecule. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • G. Christopher Anderson

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo